Literature DB >> 11360184

Cdk6-cyclin D3 complex evades inhibition by inhibitor proteins and uniquely controls cell's proliferation competence.

J Lin1, S Jinno, H Okayama.   

Abstract

Mammalian cells require a cyclin D-dependent kinase for the cell cycle start, yet many mesenchymal cells express three seemingly redundant D cyclins and similarly, seemingly redundant Cdk4 and Cdk6 as their kinase partners. We have found that the Cdk6-cyclin D3 complex is unique among the D cyclin and kinase combinations in the ability to promote the cell cycle start. In an anchorage-minus G(1)-arrested rat fibroblast, only Cdk6-D3 retains kinase activity due mainly to its ability to evade inhibition by p27(KIP1) and p21(CIP1) with a resemblance to viral cyclin-bound Cdk6. Rodent fibroblasts engineered to overexpress both Cdk6 and cyclin D3 highly resist serum starvation- or cell-cell contact-imposed G(1)-arrest. In BALB/c 3T3 cells, D3 is constitutively expressed, but Cdk6 is markedly induced with concomitant activation upon stimulation with a growth-promoting factor. These results suggest a role for the Cdk6-D3 complex in regulating cell's proliferation ability in response to external stimuli.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11360184     DOI: 10.1038/sj.onc.1204375

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  Part II-mechanism of adaptation: A549 cells adapt to high concentration of nitric oxide through bypass of cell cycle checkpoints.

Authors:  Madeeha Aqil; Zane Deliu; Kim M Elseth; Grace Shen; Jiaping Xue; James A Radosevich
Journal:  Tumour Biol       Date:  2013-11-17

2.  A Conserved Gammaherpesvirus Cyclin Specifically Bypasses Host p18(INK4c) To Promote Reactivation from Latency.

Authors:  Lisa M Williams; Brian F Niemeyer; David S Franklin; Eric T Clambey; Linda F van Dyk
Journal:  J Virol       Date:  2015-08-19       Impact factor: 5.103

3.  Cdc6 protein activates p27KIP1-bound Cdk2 protein only after the bound p27 protein undergoes C-terminal phosphorylation.

Authors:  Baasanjav Uranbileg; Hanako Yamamoto; Jung-ha Park; Atish R Mohanty; Shiho Arakawa-Takeuchi; Shigeki Jinno; Hiroto Okayama
Journal:  J Biol Chem       Date:  2012-01-05       Impact factor: 5.157

4.  The CDK4/CDK6 inhibitor PD0332991 paradoxically stabilizes activated cyclin D3-CDK4/6 complexes.

Authors:  Sabine Paternot; Bianca Colleoni; Xavier Bisteau; Pierre P Roger
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

5.  Bone morphogenetic protein 2-induced osteoblast differentiation requires Smad-mediated down-regulation of Cdk6.

Authors:  Toru Ogasawara; Hiroshi Kawaguchi; Shigeki Jinno; Kazuto Hoshi; Keiji Itaka; Tsuyoshi Takato; Kozo Nakamura; Hiroto Okayama
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

6.  The alpha-fetoprotein (AFP) third domain: a search for AFP interaction sites of cell cycle proteins.

Authors:  G J Mizejewski
Journal:  Tumour Biol       Date:  2016-07-22

7.  Overexpression of PRAS40(T246A) in the Proliferative Compartment Suppresses mTORC1 Signaling, Keratinocyte Migration, and Skin Tumor Development.

Authors:  Okkyung Rho; Jaya Srivastava; Jiyoon Cho; John DiGiovanni
Journal:  J Invest Dermatol       Date:  2016-06-24       Impact factor: 8.551

8.  Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Wen Wang; Lan Juan Zhao; Ye-Xiong Tan; Hao Ren; Zhong-Tian Qi
Journal:  World J Gastroenterol       Date:  2012-10-14       Impact factor: 5.742

9.  MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma.

Authors:  Wen Wang; Lan-Juan Zhao; Ye-Xiong Tan; Hao Ren; Zhong-Tian Qi
Journal:  Carcinogenesis       Date:  2012-02-23       Impact factor: 4.944

10.  CDK4 T172 phosphorylation is central in a CDK7-dependent bidirectional CDK4/CDK2 interplay mediated by p21 phosphorylation at the restriction point.

Authors:  Xavier Bisteau; Sabine Paternot; Bianca Colleoni; Karin Ecker; Katia Coulonval; Philippe De Groote; Wim Declercq; Ludger Hengst; Pierre P Roger
Journal:  PLoS Genet       Date:  2013-05-30       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.